Statistically significant higher median serum levels of CD27 and CD80 proteins were found in highly advanced ovarian cancer (stage III–IV) compared to low advanced ovarian cancer (stage I–II) (p = 0.02 and p = 0.03, respectively). Here, CD80 is linked to ovarian carcinoma.